HIGHLIGHTS
- who: Paolo A. Ascierto from the Department of, Cancer and Innovative Italy University Medical Center Utrecht and Princess Maxima Center, Utrecht have published the research: The u201cGreat Debateu201d at Melanoma Bridge 2022, Naples, December 1st-3rd,, in the Journal: (JOURNAL)
- what: The Melanoma Great Debate included the presentation of counterpoint views from leading experts on five contemporary clinical issues in the management of melanoma.
- future: For future trials in melanoma there should be no single agent anti-PD-1 arm as the single control arm. A triplet combination of nivolumab/ipilimumab/relatlimab may . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.